Teva Pharmaceuticals recalled 13 lots of fentanyl buccal tablets, a Type II substance, because of omitted safety updates on its medication guide, the FDA said April 28. 

Florida Rep. Cory Mills and California Rep. Sara Jacobs filed a bill April 28 that, if passed, would require drugmakers to tell the FDA if they experience a six-week-long demand increase for a product. 

Upward of 90 percent of PharmD graduates from Ada-based Ohio Northern University were placed in residency matches, according to an April 28 news release. 

As the U.S. grapples with a 10-year-high of ongoing drug shortages, there are three pressing drug supply issues for hospitals, according to Erin Fox, PharmD, associate chief pharmacy officer for shared services at Salt Lake City-based University of Utah Health. 

With hundreds of experimental gene therapies in the pipeline and development, Eric Tichy, PharmD, division chair at Mayo Clinic and an expert in the pharmacy supply chain, told Becker's he wonders who will pay for these drugs that cost seven…

Bristol Myers Squibb's CEO plans to retire Nov. 1, and the drugmaker promoted two C-suite leaders effective immediately, according to an April 26 news release. 

The FDA approved the first fecal microbiota drug to be taken orally.

Mark Cuban Cost Plus Drug Co. decreased 35 drug prices April 26, according to a news release shared with Becker's. 

The FDA added penicillin G benzathine to its drug shortages list April 26. The drug is the standard treatment for syphilis and is also used to treat strep throat. 

Clinical leaders know drug shortages are nothing new, but the current situation is incredibly challenging. Ongoing and active shortages are the highest since 2014, according to the American Society of Health-System Pharmacists (ASHP).1